MedRx Co. Ltd. announced consolidated financial results for the fiscal year ended December 31, 2019. For the period, the company's reported Net Sales were JPY 169 million compared to JPY 8 million for the same period a year ago. Operating loss was JPY 1,627 million compared to JPY 1,273 million for the same period a year ago. Loss attributable to owners of parent was JPY 1,616 million compared to JPY 1,267 million for the same period a year ago. Net loss per share was JPY 134.32 compared to JPY 126.77 for the same period a year ago.

For the year Ending June, 2020, the company expects net sales to be JPY 234 million, Operating loss to be JPY 590 million, Net loss to be JPY 593 million, and net loss per share to be JPY 43.29.

For the year Ending December, 2020, the company expects net sales to be JPY 234 million, Operating loss to be JPY 1,189 million, Net loss to be JPY 1,191 million, and net loss per share to be JPY 86.88.